Julia Marie Eastland serves as Executive at Cascadian Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Julia Marie Eastland has executed 14 insider transactions totaling $21.2K, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 9, 2026 involved selling 889 shares valued at $2.1K.
Julia Marie Eastland currently holds 79,133 shares of Cascadian Therapeutics, Inc. (CASC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Julia Marie Eastland has been a net seller of CASC stock. They have purchased $0 and sold $21.2K worth of shares.
Julia Marie Eastland's most recent insider trade was on Feb 9, 2026, when they sold 889 shares at $2.39 per share.
Get notified when new Form 4 filings are submitted
| $2.43 |
| Discretionary |
| Jan 8, 2026 | ZNTL | $0 | Award | 775,000 | $N/A | Discretionary |
| Sep 10, 2024 | LNTH | $0 | Award | 1,345 | $N/A | Discretionary |
| May 23, 2024 | DVAX | $0 | Award | 5,357 | $N/A | Discretionary |
| Mar 11, 2024 | HARP | $0 | Award | 31,250 | $N/A | Discretionary |
| Mar 11, 2024 | HARP | $0 | Disposition | 269,381 | $N/A | Discretionary |
| Jan 7, 2024 | HARP | $0 | Award | 178,500 | $N/A | Discretionary |
| Nov 26, 2023 | HARP | $0 | Award | 50,000 | $N/A | Discretionary |
| May 26, 2023 | DVAX | $0 | Award | 5,357 | $N/A | Discretionary |
| Mar 23, 2023 | GRAY | $0 | Disposition | 1,429 | $N/A | Discretionary |
| Mar 9, 2018 | CASC | $0 | Tender | 5,237 | $N/A | Discretionary |
| Jan 11, 2018 | CASC | $0 | Option Exercise | 2,825 | $N/A | Discretionary |
| Jan 11, 2018 | CASC | $3.6K | Payment | 923 | $3.92 | Discretionary |